Pa. Supreme Court Decision May Impact Hundreds of Plaintiffs
Pa. Supreme Court Decision May Impact Hundreds of Plaintiffs
Introduction
A decision by the Pennsylvania Supreme Court regarding whether it will hear the appeal involving two Risperdal lawsuits is awaited which can further impact hundreds of Risperdal lawsuits currently pending under the centralized MDL litigation in Philadelphia. Both the cases were filed in 2014 and were dismissed by the Philadelphia Court of Common Pleas granting the defendants Johnson & Johnson and its Janssen Pharmaceuticals’ motion for summary judgment after it was brought to the court’s notice that the statute of limitations on the claims had expired in 2009.
Two coordinated actions have been filed for Risperdal cases: one in Los Angeles Superior Court (Risperdal and Invega Product Liability Cases, JCCP 4775) and the other in Philadelphia (In re: Risperdal Litigation, March 2010 Term, Case No. 100300296).
Comments
Latest News
Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors
Categories: E-Cigarette: JUUL
As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.
A study published in Environmental Health Perspectives in…
Appeals Court Upholds $611M Roundup Verdict
Categories: Roundup
A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.
The case involved three plaintiffs from New…
Valsartan “Wave 2” Bellwether Trial Schedule Set by Court
Categories: Valsartan
As the first Valsartan bellwether trial approaches in September 2025, the federal judge overseeing the multidistrict litigation (MDL) is preparing a second set of trials.
This move comes in anticipation of the possibility that parties may…